3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one

C143H189F3N26O19 — CID 159195480

IUPAC3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one
SMILESC=C(C1CC1)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccc(OC)cc43)CC2)CC1.C=C(C1CC1)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccccc43)CC2)CC1.CC(=O)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccc(C)nc43)CC2)CC1.COc1ccc2c(c1)n(CC1CCC(C(=O)N3CCN(C(=O)c4nccn4C)CC3)CC1)c(=O)n2C.COc1cccc(NC(=O)C2CCC(Cn3c(=O)n(C)c4ccc(OC)nc43)CC2)c1.Cn1c(=O)n(CC2CCC(C(=O)N3CCOCC3)CC2)c2cc(C(F)(F)F)ccc21
InChIInChI=1S/C26H34N6O4.C26H36N4O3.C25H34N4O2.C23H28N4O4.C22H31N5O3.C21H26F3N3O3/c1-28-11-10-27-23(28)25(34)31-14-12-30(13-15-31)24(33)19-6-4-18(5-7-19)17-32-22-16-20(36-3)8-9-21(22)29(2)26(32)35;1-18(20-8-9-20)28-12-14-29(15-13-28)25(31)21-6-4-19(5-7-21)17-30-24-16-22(33-3)10-11-23(24)27(2)26(30)32;1-18(20-11-12-20)27-13-15-28(16-14-27)24(30)21-9-7-19(8-10-21)17-29-23-6-4-3-5-22(23)26(2)25(29)31;1-26-19-11-12-20(31-3)25-21(19)27(23(26)29)14-15-7-9-16(10-8-15)22(28)24-17-5-4-6-18(13-17)30-2;1-15-4-9-19-20(23-15)27(22(30)24(19)3)14-17-5-7-18(8-6-17)21(29)26-12-10-25(11-13-26)16(2)28;1-25-17-7-6-16(21(22,23)24)12-18(17)27(20(25)29)13-14-2-4-15(5-3-14)19(28)26-8-10-30-11-9-26/h8-11,16,18-19H,4-7,12-15,17H2,1-3H3;10-11,16,19-21H,1,4-9,12-15,17H2,2-3H3;3-6,19-21H,1,7-17H2,2H3;4-6,11-13,15-16H,7-10,14H2,1-3H3,(H,24,28);4,9,17-18H,5-8,10-14H2,1-3H3;6-7,12,14-15H,2-5,8-11,13H2,1H3
InChIKeyKOPLDVWAMGNNOJ-UHFFFAOYSA-N
MW2633.24 g/mol
LogP16.07
Rot. Bonds28

About 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one

3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one (PubChem CID 159195480) has the molecular formula C143H189F3N26O19 and a molecular weight of 2633.24 g/mol. Its IUPAC name is 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one.

Molecular Properties

Compound Name3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one
PubChem CID159195480
Molecular FormulaC143H189F3N26O19
Molecular Weight2633.24 g/mol
Exact Mass2631.46
IUPAC Name3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one
SMILESC=C(C1CC1)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccc(OC)cc43)CC2)CC1.C=C(C1CC1)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccccc43)CC2)CC1.CC(=O)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccc(C)nc43)CC2)CC1.COc1ccc2c(c1)n(CC1CCC(C(=O)N3CCN(C(=O)c4nccn4C)CC3)CC1)c(=O)n2C.COc1cccc(NC(=O)C2CCC(Cn3c(=O)n(C)c4ccc(OC)nc43)CC2)c1.Cn1c(=O)n(CC2CCC(C(=O)N3CCOCC3)CC2)c2cc(C(F)(F)F)ccc21
InChIInChI=1S/C26H34N6O4.C26H36N4O3.C25H34N4O2.C23H28N4O4.C22H31N5O3.C21H26F3N3O3/c1-28-11-10-27-23(28)25(34)31-14-12-30(13-15-31)24(33)19-6-4-18(5-7-19)17-32-22-16-20(36-3)8-9-21(22)29(2)26(32)35;1-18(20-8-9-20)28-12-14-29(15-13-28)25(31)21-6-4-19(5-7-21)17-30-24-16-22(33-3)10-11-23(24)27(2)26(30)32;1-18(20-11-12-20)27-13-15-28(16-14-27)24(30)21-9-7-19(8-10-21)17-29-23-6-4-3-5-22(23)26(2)25(29)31;1-26-19-11-12-20(31-3)25-21(19)27(23(26)29)14-15-7-9-16(10-8-15)22(28)24-17-5-4-6-18(13-17)30-2;1-15-4-9-19-20(23-15)27(22(30)24(19)3)14-17-5-7-18(8-6-17)21(29)26-12-10-25(11-13-26)16(2)28;1-25-17-7-6-16(21(22,23)24)12-18(17)27(20(25)29)13-14-2-4-15(5-3-14)19(28)26-8-10-30-11-9-26/h8-11,16,18-19H,4-7,12-15,17H2,1-3H3;10-11,16,19-21H,1,4-9,12-15,17H2,2-3H3;3-6,19-21H,1,7-17H2,2H3;4-6,11-13,15-16H,7-10,14H2,1-3H3,(H,24,28);4,9,17-18H,5-8,10-14H2,1-3H3;6-7,12,14-15H,2-5,8-11,13H2,1H3
InChIKeyKOPLDVWAMGNNOJ-UHFFFAOYSA-N
XLogP16.07
TPSA429.08 Ų
H-Bond Donors1
H-Bond Acceptors37
Rotatable Bonds28
Heavy Atoms191
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002633.24
LogP ≤ 516.07
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1037

Analyze 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one?
The IUPAC name of 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one (CID 159195480) is 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one.
What is the SMILES notation for 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one?
The canonical SMILES for 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one is C=C(C1CC1)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccc(OC)cc43)CC2)CC1.C=C(C1CC1)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccccc43)CC2)CC1.CC(=O)N1CCN(C(=O)C2CCC(Cn3c(=O)n(C)c4ccc(C)nc43)CC2)CC1.COc1ccc2c(c1)n(CC1CCC(C(=O)N3CCN(C(=O)c4nccn4C)CC3)CC1)c(=O)n2C.COc1cccc(NC(=O)C2CCC(Cn3c(=O)n(C)c4ccc(OC)nc43)CC2)c1.Cn1c(=O)n(CC2CCC(C(=O)N3CCOCC3)CC2)c2cc(C(F)(F)F)ccc21.
What is the InChIKey of 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one?
The InChIKey is KOPLDVWAMGNNOJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H34N6O4.C26H36N4O3.C25H34N4O2.C23H28N4O4.C22H31N5O3.C21H26F3N3O3/c1-28-11-10-27-23(28)25(34)31-14-12-30(13-15-31)24(33)19-6-4-18(5-7-19)17-32-22-16-20(36-3)8-9-21(22)29(2)26(32)35;1-18(20-8-9-20)28-12-14-29(15-13-28)25(31)21-6-4-19(5-7-21)17-30-24-16-22(33-3)10-11-23(24)27(2)26(30)32;1-18(20-11-12-20)27-13-15-28(16-14-27)24(30)21-9-7-19(8-10-21)17-29-23-6-4-3-5-22(23)26(2)25(29)31;1-26-19-11-12-20(31-3)25-21(19)27(23(26)29)14-15-7-9-16(10-8-15)22(28)24-17-5-4-6-18(13-17)30-2;1-15-4-9-19-20(23-15)27(22(30)24(19)3)14-17-5-7-18(8-6-17)21(29)26-12-10-25(11-13-26)16(2)28;1-25-17-7-6-16(21(22,23)24)12-18(17)27(20(25)29)13-14-2-4-15(5-3-14)19(28)26-8-10-30-11-9-26/h8-11,16,18-19H,4-7,12-15,17H2,1-3H3;10-11,16,19-21H,1,4-9,12-15,17H2,2-3H3;3-6,19-21H,1,7-17H2,2H3;4-6,11-13,15-16H,7-10,14H2,1-3H3,(H,24,28);4,9,17-18H,5-8,10-14H2,1-3H3;6-7,12,14-15H,2-5,8-11,13H2,1H3.
What are the key properties of 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one?
3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one has a molecular weight of 2633.24 g/mol, XLogP of 16.07, 28 rotatable bonds, 1 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[4-(4-acetylpiperazine-1-carbonyl)cyclohexyl]methyl]-1,5-dimethylimidazo[4,5-b]pyridin-2-one;3-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-5-methoxy-1-methylbenzimidazol-2-one;1-[[4-[4-(1-cyclopropylethenyl)piperazine-1-carbonyl]cyclohexyl]methyl]-3-methylbenzimidazol-2-one;5-methoxy-1-methyl-3-[[4-[4-(1-methylimidazole-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]methyl]benzimidazol-2-one;4-[(5-methoxy-1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)methyl]-N-(3-methoxyphenyl)cyclohexane-1-carboxamide;1-methyl-3-[[4-(morpholine-4-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)benzimidazol-2-one is sourced from PubChem (CID 159195480), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).